Project BioShield Act

The Project BioShield Act, enacted in 2004, is a U.S. government initiative designed to develop, acquire, and stockpile medical countermeasures—such as vaccines and treatments—to protect Americans from bioterrorism and biological threats. It provides funding and regulatory support to speed up the creation of these defenses against dangerous pathogens like anthrax and smallpox, ensuring rapid response capabilities in case of bioterrorist attacks or emerging biological emergencies.